Skip to content

Clinical trials

Completed Carcinoma, Transitional Cell trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Transitional Cell Status: Completed Country / region: Germany Clear all

18 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20081
20101
20111
20131
20152
20173
20183
20194
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed18

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Bayer2
Eli Lilly and Company2
Incyte Corporation2
Achieve Life Sciences1
Astellas Pharma Inc1
Basilea Pharmaceutica1
Bristol-Myers Squibb1
Daiichi Sankyo1
EMD Serono Research & Development Institute, Inc.1
Ludwig Institute for Cancer Research1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Transitional Cell18
Urinary Bladder Neoplasms9
Breast Neoplasms3
Urethral Neoplasms3
Acrocephalosyndactylia2
Carcinoma, Non-Small-Cell Lung2
Carcinoma, Renal Cell2
Melanoma2
Neoplasm Metastasis2
Ovarian Neoplasms2

Trials

Showing 1 to 18 of 18. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.